According to projections, the global sleep aid devices industry demand will be worth roughly US$ 68354.36 million in 2022 and US$ 133211.98 million by 2032. The market is anticipated to expand at a 6.9% CAGR from 2022 to 2032. As the prevalence of sleep problems and insomnia has continued to climb, the Sleep Aid Devices …
Category Archives: Healthcare Trends
Global Oral Antiseptics Industry in North America and East Asia anticipates a stable 4.7% CAGR till 2028 | FMI
The global oral antiseptics industry size is set to witness an unprecedented surge, with projections indicating a substantial rise from a valued US$ 2.47 billion in 2022 to an estimated US$ 3.24 billion by 2028. This anticipated growth is substantiated by a promising Compound Annual Growth Rate (CAGR) of 4.7%. The Oral Antiseptics Market has …
Over-the-Counter Pain Medication Industry Poised for Skyrocketing Success, Targeting a US$ 27.7 Billion Valuation by 2028-FMI Report
The over-the-counter (OTC) painkillers industry is expected to reach US$ 21.8 billion in 2022, according to a recent analysis by Future Market Insights (FMI). The growth of this market is expected to be impacted by changing perceptions of generic prescription medications. The analysis projects that market sales would rise at a faster 4.1% annual pace …
Global Brain Monitoring Systems Industry is estimated at US$ 8.5 Billion by 2033, is highlighted by FMI
The global brain monitoring systems industry size is poised for substantial growth according to recent projections, with an anticipated rise at a Compound Annual Growth Rate (CAGR) of 5.5% from 2023 to 2033. These findings, unveiled in a comprehensive market analysis report, forecast the market to soar from a value of US$ 5.0 billion in …
Seasonal Affective Disorder Therapeutics Industry Radiant Growth on the Horizon, Anticipated to Achieve US$ 1.1 Billion by 2028-FMI Report
The research states that SSRIs, or selective serotonin reuptake inhibitors, are often prescribed drugs for the treatment of seasonal affective disorder. In the market for seasonal affective disorder treatments industry, there are numerous branded and generic drugs accessible, however Buproban and Citalopram continue to sell at a comparatively greater rate. FMI attributes this supremacy to …
Global 3D Cell Culture Industry will attain US$ 3 Billion by 2033, with a 9% CAGR | FMI
Innovation and advancement in the field of 3D cell culture industry demand are poised to redefine the landscape of research methodologies. According to industry projections, the 3D cell culture market, currently valued at US$ 1.26 billion in 2023, is anticipated to undergo an unprecedented surge, soaring to an estimated US$ 3 billion by 2033. This …
Global Psoriatic Arthritis (PsA) Treatment Industry is poised to culminate in US$ 15.6 Billion by 2028, driven by innovation and a focus on patients | FMI
In 2022, the psoriatic arthritis (PsA) treatment industry size is expected to generate sales of more than US$ 10.3 billion. By 2028, the market size is anticipated to reach US$ 15.6 billion, growing at a strong 7.1% CAGR. Furthermore, small molecule targeted therapies have also emerged as a valuable addition to the treatment arsenal. Janus …
Dental Lasers Industry Set to Shine Bright Projected to Illuminate at US$ 737.4 Million by 2033-FMI Report
The dental lasers industry is projected to reach a value of US$ 492.2 million by 2023 and US$ 737.4 million by 2033. Sales of dental lasers are expected to rise at a noteworthy CAGR of 4.1% over the course of the projected year. The recent advancements in laser technology have also contributed to the steady …
Cytomegalovirus Treatment Industry Surges to a Remarkable US$ 326 Million by 2028-FMI Report
The cytomegalovirus (CMV) treatment industry is at the forefront of tackling a formidable viral foe that frequently goes unchecked. HIV-positive persons and transplant recipients are among the groups of people whose immune systems are compromised by the herpesvirus cytomegalovirus, which can be very deadly. The development of effective therapies has therefore grown to be a …
Global Canine Arthritis Treatment Industry to Reach US$ 3.05 Billion by 2028, Growing at a CAGR of 4.2% | FMI
In 2022, the global canine arthritis treatment industry size will have a net worth of US$ 2.39 billion. By 2028, the market for pharmaceuticals used to treat canine arthritis is expected to be worth US$ 3.05 billion, growing at a CAGR of 4.2%. Canine arthritis is a degenerative joint disease caused by frequent rubbing, cartilage …